[2022] The structure of AcrIE4-F7 reveals a common strategy for dual CRISPR inhibition by targeting PAM recognition sites
Journal
Nucleic Acids Res 50(4):2363-2376
Authors
Hong, S.H.#, Lee, G.#, Park, C., Koo, J., Kim, E.H., Bae, E.*, Suh, J.Y.*
#Denotes Equal Contribution
*Denotes Corresponding Author
Abstract
Journal
Nucleic Acids Res 50(4):2363-2376
Authors
Hong, S.H.#, Lee, G.#, Park, C., Koo, J., Kim, E.H., Bae, E.*, Suh, J.Y.*
#Denotes Equal Contribution
*Denotes Corresponding Author
Abstract
Bacteria and archaea use the CRISPR-Cas system to fend off invasions of bacteriophages and foreign plasmids. In response, bacteriophages encode anti-CRISPR (Acr) proteins that potently inhibit host Cas proteins to suppress CRISPR-mediated immunity. AcrIE4-F7, which was isolated from Pseudomonas citronellolis, is a fused form of AcrIE4 and AcrIF7 that inhibits both type I-E and type I-F CRISPR-Cas systems. Here, we determined the structure of AcrIE4-F7 and identified its Cas target proteins. The N-terminal AcrIE4 domain adopts a novel α-helical fold that targets the PAM interaction site of the type I-E Cas8e subunit. The C-terminal AcrIF7 domain exhibits an αβ fold like native AcrIF7, which disables target DNA recognition by the PAM interaction site in the type I-F Cas8f subunit. The two Acr domains are connected by a flexible linker that allows prompt docking onto their cognate Cas8 targets. Conserved negative charges in each Acr domain are required for interaction with their Cas8 targets. Our results illustrate a common mechanism by which AcrIE4-F7 inhibits divergent CRISPR-Cas types.